Dear Friends & Colleagues,
I am glad to meet and greet you through the March 2013 edition of the newsletter of Oviya MedSafe Private Limited – our Pharmacovigilance Consulting & Services company! With the month of February 2013 having been eventful and enthusiastic for us, it is my pleasure to share with you some snippets of the landmarks of our interesting journey so far, which we crossed during the vibrant month.
On 07-Feb-2013, Ma Foi Strategic Consultants Pvt Ltd convened a press meet at Chennai to formally announce their investment in Oviya MedSafe, which was our first opportunity to engage the media on pharmacovigilance. The event also provided a platform for Ma Foi to explain the background of Ma Foi making the early stage investment in Oviya MedSafe and also elucidate on the long-term plans by which Ma Foi’s strengths would be leveraged to Oviya MedSafe’s advantage and vice versa. The photos of the event can be viewed here. The following are the links to some of the key news reports that followed the press meet:
- The Hindu Business Line – Ma Foi Strategic acquires 17.5% stake in Oviya MedSafe
- The Financial Express – Ma Foi enters pharma consulting, picks stake in Oviya MedSafe
- Pharmabiz – Physicians in Coimbatore launch co offering pharmacovigilance services
- Business Standard – Ma Foi Strategic acquires stake in Oviya MedSafe
- Financial Chronicle – Ma Foi eyes outsourcing in pharmacovigilance
- Sulekha – Ma Foi enters Indian pharma segment (Detailed Coverage)
Following the successful press meet, Oviya MedSafe organised a workshop titled ‘Pharmacovigilance for Aspiring Professionals’ by renowned speaker Mr Moin Don, to mark the formal launch of the company on 23-Feb-2013 at Coimbatore. The workshop was chaired by Mr Yagya Prasad Neupane, Chairman of Nepal Pharmacy Council, Kathmandu. Mr Neupane was also the chief guest for the launch of the company, which was felicitated by Dr L P Thangavelu and Dr J A Jayalal, the President and the Secretary of the Indian Medical Association – Tamil Nadu State Branch respectively. Mr Sudhir Kandarth from Oracle Health Sciences Global Business Unit also felicitated the function.
A detailed report on the workshop and the inauguration is available here. We are happy to share the complete set of photographs of the events, which can be viewed here. Our pharmacovigilance initiatives at Coimbatore received very positive coverage in The Hindu and Pharmabiz with the other media to follow up shortly. The URL’s of the articles are shared below:
Following the formal launch of the company, our global delivery centre at Coimbatore has now become fully operational, with a robust drug safety team consisting of experienced as well as entry level pharmacovigilance professionals. With this strong team, we are confident of providing end-to-end pharmacovigilance support. We are pleased to inform you that we have in-house capabilities for writing risk management plans, the requirement of which has now become more frequent, after the implementation of the new EU regulations.
On the event front, we are exhibiting at the 4th Pharmacovigilance Conference of the Drug Information Association India at Bangalore on March 8th & 9th, 2013. Oviya MedSafe has also been given an ‘Event Partner’ status consecutively for the second year by IQPC Singapore, a leading global conference management company, for their 4th Annual Pharmacovigilance Asia 2013 conference which is scheduled to happen from 18th to 21st June, 2013 at Singapore.
Before concluding, I would like to share with you three professional recognitions I received during the past 2 months, as follows:
- Executive Committee Member – Indian Society for Clinical Research – April 2013 to March 2015
- Affiliate Member – Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom – 2013
- Joint Secretary – Indian Medical Association, Coimbatore Branch – 2013
I believe that with the help of the above-mentioned positions and your consistent support, I will be able to put in my best efforts for the larger cause of Indian Pharmacovigilance, which is of course a shared goal for all of us, beyond business interests. I thank you very much for your patient reading of this long letter and am keen to respond to your comments and questions, which you may have.
Looking forward to meeting you in April 2013 with more interesting news,
With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA
Managing Director & CEO,
Oviya MedSafe Pvt. Ltd.
Pharmacovigilance Consulting & Services